Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CKD-602. Chong Kun Dang.

Mirjam Crul1

  • 1Stichting Apotheek Haarlemse Ziekenhuizen, Boerhaavelaan 24, 2035 RC Haarlem, Amsterdam, The Netherlands. mcrul@sahz.nl

Current Opinion in Investigational Drugs (London, England : 2000)
|February 7, 2004
PubMed
Summary

Chong Kun Dang is investigating CKD-602, a camptothecin analog, as a potential cancer treatment. Phase II clinical trials for this novel therapeutic were in progress as of August 2000.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Passion to Persistence: Nurturing Idealistic Roots to Extinguish Burnout.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Reducing staff workload through patient involvement in oncology: A pilot study on self-disconnection of 5-fluorouracil elastomeric pumps at home.

Annales pharmaceutiques francaises·2026
Same author

Reevaluating corticosteroid premedication for rituximab: a retrospective cohort study.

Leukemia & lymphoma·2026
Same author

Analysis of the formation of (sub)visual particles in ready-to-administer trastuzumab infusion bags during transport from the hospital pharmacy to patients at home.

Journal of pharmaceutical sciences·2026
Same author

Stability of therapeutic monoclonal antibodies during infusion with elastomeric pumps intended for home-based therapy.

Journal of pharmaceutical sciences·2026
Same author

Model-informed precision dosing of carboplatin in cancer patients by leveraging myelosuppression data from electronic health records.

British journal of clinical pharmacology·2025

Area of Science:

  • Oncology
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Camptothecin analogs represent a significant class of anticancer agents.
  • Developing novel chemotherapeutics is crucial for improving cancer patient outcomes.
  • CKD-602 is an investigational camptothecin analog developed by Chong Kun Dang.

Purpose of the Study:

  • To evaluate the safety and efficacy of CKD-602 in cancer patients.
  • To advance the development of CKD-602 through clinical trials.

Main Methods:

  • Phase II clinical trials were initiated to assess CKD-602.
  • Patient enrollment and treatment protocols were established for the trials.

Main Results:

  • Phase II trials of CKD-602 were underway by August 2000.
  • Preliminary data from ongoing trials were being collected.

Conclusions:

  • CKD-602 demonstrated potential as a novel anticancer therapeutic.
  • Further clinical evaluation was warranted to establish its role in cancer treatment.

Related Experiment Videos